Taste, Nutrition & Health

The GLP-1 opportunity and beyond

The global weight management landscape is rapidly transforming, driven by the emergence of GLP-1* receptor agonists (GLP-1 RAs) like Ozempic and Wegovy. This trend signals a shift towards food options that can support health goals, with consumers prioritizing satiety-focused and scientifically validated solutions. Post-pandemic, health has become a primary driver for food and beverage choices, fostering a holistic view that integrates nutrition and overall well-being, encompassing both physical and mental health.

As overweight and obesity rates continue to rise globally, consumers are actively seeking simpler, more effective methods for weight management that also support broader health objectives. This growing health awareness and popularity of GLP-1 RAs pushes the demand for integrated wellness strategies which creates a significant market opportunity for the food and beverage industry.

Symrise, with its extensive ingredient portfolio and market expertise, is perfectly positioned to partner with manufacturers to develop innovative products that meet these evolving consumer needs and capitalize on this transformative weight management market.

Featured content
Symrise Food & Beverage Trend UpdateMore

Inspiring market insights

Woman eating a salad outdoorsMore

Download our brochure

Download


* GLP-1 is a hormone your body releases after eating. It helps to control blood sugar by boosting insulin, slowing digestion, and reducing appetite, leading to a feeling of fullness.

GLP-1 receptor agonists (GLP-1 RAs) are medications that mimic and act like this hormone. They can help to manage diabetes and obesity by lowering blood sugar and often reducing appetite, which can lead to weight loss.

Woman drinking an isotonic drink whike exercising

Consumer interest goes beyond GLP-1 RAs

The advent and increasing accessibility of GLP-1 RAs have dramatically disrupted the weight management sector. These medications mimic a natural hormone that regulates blood sugar and appetite, leading to significant weight loss by effectively reducing hunger and promoting prolonged feelings of satiety. Their demonstrable efficacy has cemented their status as a go-to solution for many, driving substantial market growth and unprecedented consumer awareness.

GLP-1 RAs are the most prominent example for prescription drugs for weight management, but consumers go beyond: They are interested in any kind of products supporting them in reaching their weight management goals – be it prescription drugs or more gentle solutions like functional food and beverages. This shift presents both a challenge and a clear opportunity for the industry to adapt and innovate, offering satiety-focused and supportive solutions for this growing consumer base of people aiming to manage their weight.

weight loss infographic
Person eating a healthy meal and looking at their smartphone

Filling the satiety management gap

While the focus on weight management is intensifying, there remains a significant opportunity to innovate beyond existing product formulations. The opportunity lies in developing food and beverage innovations focusing on several key strategic pillars:

Would you like to learn how our solutions can support you in developing food and beverage innovations that support consumers’ weight management journeys? 
 

Contact us